Pancreatic Cancer Research

ResearcherHenan UniversityActive in the last 2 years

Zheng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6141-4990; OpenAlex author ID A5100415008. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. PD-L1 levels, TP53 mutation profiles, and survival outcomes in pancreatic cancer differ by immune-nutritional status. Co-author DOI 10.1186/s12957-025-03818-x↗
  2. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer. Co-author PMID 26823712↗
  3. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2013.12.021↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hu Ren · 1 shared paper, 2025 · strength 0.25
  2. Dongbing Zhao · 1 shared paper, 2025 · strength 0.25
  3. Zhikuan He · 1 shared paper, 2015 · strength 0.08
  4. Kun-Ling Xie · 1 shared paper, 2014 · strength 0.04
  5. Zekuan Xu · 1 shared paper, 2014 · strength 0.04
  6. Xiaofei Zhi · 1 shared paper, 2014 · strength 0.04
  7. Jie Tang · 1 shared paper, 2014 · strength 0.04
  8. Jingjing Zhang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.